Inclusivity of diverse populations in clinical research is the best way to ensure clinical equity for patients worldwide. The reality of this is especially evident now, as it has become an underlying imperative in clinical research that better reflects the real-world. Watch our on demand webinar, as our panelists explore the new draft guidance “Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; a Draft Guidance for Industry; Availability”, where it falls short, and what our industry still needs to address in order to make clinical trials more inclusive for all.